Azvudine
FNC-Covid304
Phase 3 small_molecule active
Quick answer
Azvudine for SARS-CoV-2 Infection is a Phase 3 program (small_molecule) at Shanghai Henlius Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai Henlius Biotech
- Indication
- SARS-CoV-2 Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active